Correlation Between Candel Therapeutics and Palatin Technologies
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Palatin Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Palatin Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Palatin Technologies, you can compare the effects of market volatilities on Candel Therapeutics and Palatin Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Palatin Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Palatin Technologies.
Diversification Opportunities for Candel Therapeutics and Palatin Technologies
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Candel and Palatin is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Palatin Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palatin Technologies and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Palatin Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palatin Technologies has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Palatin Technologies go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Palatin Technologies
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 2.7 times more return on investment than Palatin Technologies. However, Candel Therapeutics is 2.7 times more volatile than Palatin Technologies. It trades about 0.22 of its potential returns per unit of risk. Palatin Technologies is currently generating about -0.2 per unit of risk. If you would invest 447.00 in Candel Therapeutics on September 13, 2024 and sell it today you would earn a total of 328.00 from holding Candel Therapeutics or generate 73.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Palatin Technologies
Performance |
| Timeline |
| Candel Therapeutics |
| Palatin Technologies |
Candel Therapeutics and Palatin Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Palatin Technologies
The main advantage of trading using opposite Candel Therapeutics and Palatin Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Palatin Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palatin Technologies will offset losses from the drop in Palatin Technologies' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Palatin Technologies vs. Fortress Biotech | Palatin Technologies vs. Checkpoint Therapeutics | Palatin Technologies vs. Avenue Therapeutics | Palatin Technologies vs. Pieris Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |